INTRODUCTION
In response to a variety of stimuli, the haematopoietic stem cells located in the bone marrow are able to proliferate and differentiate to produce all types of mature blood cells. During this process, changes occur in the adhesive properties of the cells [1] . In pathological situations such as leukaemia where the process of proliferation is abnormal, the adhesive properties of leukaemia cells may play a role in the progression and phenotypic properties of the disease [2, 3] .
Through second messenger activation, protein kinase C plays a key role in signal transduction and in the modulation of gene expression linked to proliferative and differentiation events [4, 5] . Protein kinase C activators, such as phorbol esters, induce differentiation of immature haematopoietic cells [6] . Upon exposure to phorbol 12-myristate 13-acetate (PMA), T-cells are activated [7] , whereas promyelocytic leukaemia cell lines lose their myeloblast marker genes and acquire a series of monocyte/ macrophage properties [8, 9] . On platelets, phorbol esters stimulate fibrinogen binding [10] and phosphorylation of the focal adhesion kinase via a protein kinase C-mediated pathway [11] . In erythroleukaemia cell lines, such as HEL, phorbol esters induce the surface expression of platelet glycoprotein aIIb/?3 and increase the ploidy of the cells [12, 13] . HEL cells normally grow in suspension, but PMA induces the organization of the actomyosin system of these cells by promoting the formation of prominent actin stress fibres and focal adhesion sites, thus leading to an adherent phenotype [14] .
Integrins are adhesive receptors that are concentrated in focal contacts and are likely to play a role in the attachment and integrins. After PMA induction, /J1 integrin expression was totally abolished in AP217 cells and the amount of /11 mRNA was reduced preventing new synthesis of the subunit. In HEL and LAMA-84 cells, PMA treatment did not alter the overall level of fll integrin but induced a new pattern of a-subunit expression: up-regulation of a2 and av subunits and downregulation of a4 and a5 subunits. Function-perturbing antibodies against flu, a4, a5, av and a2 reduced adhesion of HEL cells to fibronectin or collagen, whereas antibodies against 8l3 or av,83 did not. Our results favour the involvement of fll integrins in PMA-induced adhesion of erythroleukaemia cells.
spreading of HEL cells. These heterodimeric glycoproteins, composed of non-covalently associated subunits, form a critical link between the extracellular matrix and the cytoskeleton. At present 16 a and eight fi subunits have been described, but only 20 different combinations have been identified [15, 16] . HEL cells express several integrin receptors, including the fibronectin receptor (acS#1), the platelet glycoprotein aIIb,f3 and the a subunit of the vitronectin receptor (av). By immunofluorescence detection on HEL cells, Yliinne et al. [17] showed that aIIb, fl3, a5 and/1 localize to focal contacts within 2 h of PMA treatment.
After 24 h in culture, aIcb immunoreactivity disappears from focal adhesion sites and there are variations in other integrin subunits, depending on the matrix used. They also showed that HEL cells deposit thrombospondin on to the culture substratum and express the integrin subunits av and ,83, which might bind thrombospondin. On the basis of these observations, Ylanne et al. have postulated that HEL adherence under PMA treatment is mediated first by the activation of the acIIb,3 integrin complex and later by the av,83 complex.
To assess directly the involvement of specific integrin receptors in PMA-induced adhesion of erythroleukaemia cell lines, we have made use of two unique reagents developed in this laboratory: a monoclonal antibody AC7 which is specific for the activated state of aIIbfl3 [18] and an erythromegakaryocytic cell line, AP217 which behaves in many respects like HEL but does not adhere after PMA induction. We found that although cell surface expression of acIIbf3 integrin increased after PMA treatment of HEL cells, the monoclonal AC7 was unable to recognize it. Thus, since this integrin receptor reaches the cell surface in a non-activated conformation, the initial adhesion MATERIALS AND METHODS Cells HEL is an erythromegakaryocytic cell line developed from a patient who contracted leukaemia after treatment for a solid tumour [19] . LAMA-84 and AP217 were both established from peripheral blood of patients with chronic myeloid leukaemia in acute phase [20] . AP217 is a new cell line established in our laboratory in January 1992; cells have been continuously growing from this date with a doubling time of 20 h [21] . LAMA-84 and AP217 have morphological features of undifferentiated blast cells, but like HEL they have immunological characteristics of the megakaryocytic lineage. Cells were maintained in RPMI 1640 medium supplemented with 10% (v/v) fetal calf serum (FCS) and antibiotics. For differentiation experiments, growing cells were subcultured at a density of 0.5 x 105 cells/ml, and PMA (100 nM) was added to the medium. The treatment was stopped by washing cells twice with PBS.
Antibodies and peptides
B2A is an anti-,/3 monoclonal antibody raised against purified human ,B3 [22, 23] , and AC7 is elicited against a synthetic peptide located within the RGD (Arg-Gly-Asp) binding region of /3 [24] . AC7 recognizes only the activated form of the integrin allb/33. Monoclonal B2A recognizes the integrin ,/3 subunit and inhibits platelet aggregation [25] as well as the adhesion of platelets to fibronectin. A concentration of 3 #sg/ml of B2A abolished 50 % of the fibronectin binding to thrombin-activated platelets (platelets at 1 x 108/ml and fibronectin at 20 jug/ml; D.
Gulino, personal communication).
Function-perturbing antibodies were obtained from the fol- Wells were washed with PBS and blocked with 100,1 of 0.2 % BSA in PBS for 1 h, followed by three washes with PBS. HEL cells, grown for 72 h in the presence of 100 nM of PMA, were harvested with 0.05 % trypsin/0.02 % versene and washed in serum-free Dulbecco's modified Eagle's medium containing 0.2% soybean trypsin inhibitor (Sigma Chemical Co.). Cells were plated at a density of 1.5 x 104 in 100 ,u1 in the presence of PMA (100 nM). Some assays were run in the presence of competitors: GRGDSP and GRGESP peptides at 100 nM, antiav/33 (LM609, dilution 1:10 of ascites), anti-a4 (L25, 100 mg/ml), anti-a5 (B2GII, hybridoma supernatant), anti-,/1 (A2BII, hybridoma supernatant), anti-,/3 (B2A, 100 ,ug/ml), antia2 (VM 1, dilution 1: 200 ofascites) and anti-av (L230, hybridoma supernatant). To achieve an even distribution of cells, plates were spun at 3500 g for 10 s and incubated at 37°C for 30 min. After incubation, plates were shaken on an orbital shaker (300 rev./min for 30 s) then washed three times with PBS. At the end of the wash, no cells remained adherent to the BSA-coated wells. Cell adherence was quantified using a protein quantification kit, BCA (Pierce, Rockford, IL, U.S.A.), by adding 100 1ld of BCA reagent to each well, incubating for 1 h at 37°C and then reading on a plate reader (Molecular Devices Corp., Menlo Park, CA, U.S.A.) at 562 nm.
Indirect Immunofluorescence and flow cytometry
Cells were grown in the presence of 100 nM PMA for various times. Adherent cells (HEL, LAMA-84) were washed twice in PBS and were scraped off with a rubber policeman, suspended in PBS and counted. Non-adherent cells (AP217) were washed three time in PBS before counting. Surface expression of individual integrins was evaluated by flow cytometry after staining of 500000 cells with integrin-subunit-specific antibodies followed by fluorescein isothiocyanate-conjugated secondary antibody (anti-mouse IgG from Jackson Immunoresearch Laboratories, Inc., West Grove, PA, U.S.A.). Commercially available antiintegrin antibodies were used at the dilution suggested by the manufacturer, otherwise anti-/3 and anti-aIIb/33 antibodies (B2A and AC7) were used at 4 ,g/ml. Antibody not binding specifically was removed by washing with phosphate buffer. Non-specific staining was assessed by using non-immune mouse IgG as primary antibody. Routinely, 10000 cells were analysed in a Becton Dickinson flow cytometer.
RNA purmcatlon and amplfflcation procedure Cytoplasmic RNA was isolated according to Gough's method [25] . With this procedure, 4 + 0.5 ,ug of cytoplasmic RNA per 106 cells was obtained. Contaminating DNA was eliminated by digestion with Promega RNase-free DNase according to the manufacturer's instructions. mRNA (corresponding to 2 jug of total RNA) was reverse-transcribed to prepare first-strand cDNA. The reaction was performed for 2 h at 37°C with 100 units of reverse transcriptase (GIBCO-BRL, Gaithersburg, MD, U.S.A.) and two 3' oligonucleotides chosen from within human GAPDH (glyceraldehyde-3-phosphate dehydrogenase) and integrin fll sequences. In a control experiment the enzyme was omitted. Part of the cDNA (corresponding to 300 ng of RNA) was amplified using the following primer sets: either 5'-GACC-TCTACTACCTTATGGAC-3' and 5'-GGCATCGAAACCA-CCTTCTGG-3' to amplify base pair 533 to 865 from human f81 integrin, or 5'-CTCAAGATCATCAGCAATGC-3' and 5'-AGCTTCCCGTTCAGCTCAG-3' to amplify base pair 490 to 743 from human GAPDH. Amplification steps were carried out with a Techne terminal cycler, using the following program: 1 min at 94°C, 1 min at 50°C, 1.5 min at 72°C during 22 cycles and one final extension step at 72°C for 4 min. Amplification products were subjected to electrophoresis and analysed by Southern blotting.
Southern blotting PCR products were run on 1.5 % Sea plaque agarose gel (FMC bioproducts, Rockland, ME, U.S.A.) and electrophoretically transferred to a Hybond N+ membrane (Amersham, Arlington Heights, IL, U.S.A.). Amplified fragments were detected with the Amersham rapid hybridization system using 32P-labelled cDNA probes. The integrin ff1 probe corresponded to a fragment of the human cDNA from positions 607 to 865 (Genbank, HUMFNRB). GAPDH was detected by the Nsil-BstXI digestion fragment of the rat GAPDH cDNA corresponding to the sequence from nucleotides 515 to 703 (Genbank, RATGAPDH). Both probes were labelled by incorporation of [a6-32P]dCTP using a random priming kit (Boerhinger, Mannheim, Germany). After extensive washes, the membrane was autoradiographed and the radioactive spots were counted for 10 min in the absence of scintillator liquid (Cerenkov counting).
RESULTS
In response to PMA, HEL and LAMA-84 cells adhered but AP217 cells did not HEL and LAMA-84 phenotypes display characteristics of both the erythroid and the megakaryocytic lineage [19, 20] .
AP217 is a new cell line established from the blood of a patient with chronic myeloid leukaemia in the acute phase. Having been established now for about three years, AP217 line continues to proliferate rapidly and exhibits a stable phenotype [21] . This cell line is negative for lymphocyte markers, but spontaneously expresses immature granulo-monocytic (CD33, CD1 lb) as well as platelet-megakaryocytic and erythroid markers. AP217 erythroid markers are represented by f8 and y globins, EPO- receptors, transcription factor GATA-1 and glycophorin A. Platelet GPIIb RNA and GPIIbIIIa were expressed by 24 % of the cells together with c-mpl receptor for thrombopoietin. C-mpl or cellular proto-oncogene of the myelo-proliferative leukaemia virus is a specific megakaryocytic growth factor that was cloned recently [26] . The megakaryocytic characteristics of this cell line are also strengthened by the increased ploidization of the cells after PMA induction (30 % of the cells being 8N).
HEL, LAMA-84 and AP217 normally grow in suspension, but when they were cultured in the presence of PMA, HEL and LAMA-84 exhibited an adherent phenotype while AP217 did not still expressed high levels of fl1, but the level of this receptor decreased dramatically in AP217 cells (81.2% to 4.3%). To identify which a subunits are associated with the /81 subunit we quantified the expression of a6, a4 and a5 subunits by flow cytometry using several monoclonal antibodies. Without PMA treatment, the three cell lines did not express any detectable a6 subunit but all of them expressed a4 and a5 (Table 2) . After 72 h of PMA induction, the three cell lines still did not express a6 and we observed a variable decrease in expression of a5 and ac4 subunits ( Figure 2 , the up-regulation of a2 and av was rapid; indeed, after 4 h of PMA induction newly synthesized integrins were already detected at the cell surface. The matrix molecule thrombospondin may also be involved in the adhesive properties of erythromegakaryocytic leukaemia cell lines; therefore we examined the expression of thrombospondin receptor, CD36 [27] , in the three cell lines ( 128] which is a tyrosine phosphatase, remained constant at the surface of the three cell lines (Table 2) . Thus, erythroleukaemia cell membranes are not completely remodelled upon PMA treatment.
After PMA induction, HEL cells used fll and not fl3 integrins to adhere to flbronectin
We showed that after 72 h of induction by PMA, HEL cells expressed a4/I1, az5/Il, a2/ll, allb/3 and av subunit on the cell surface. To verify that the adhesion of HEL is integrin mediated, we performed adhesion assays in the presence of competitors. As indicated in Table 3 , the adhesion of HEL to fibronectin was RGD-dependent, confirming the involvement of integrin receptors. Indeed, GRGDSP peptide reduced the adhesion of HEL to fibronectin by 82% whereas negative control peptide GRGESP did not. To assess the roles of specific integrins, we performed adhesion assays on fibronectin in the presence of various blocking antibodies. We first used antibodies against the /I subunits; antibody against/,1 integrin [29] reduced the adhesion of HEL to fibronectin by 70 % whereas antibodies against /I3 or av,83 [30] did not ( [32] . As expected, no signal was obtained when the reverse transcriptase was omitted ( Figure 3, lane 1) , thus confirming the absence of contaminating DNA. Amplification of GAPDH mRNA was used to monitor the integrity of RNA samples and to quantify the relative intensity of the radioactive spots obtained after electrophoretic transfer and hybridization with specific probes. Experiments were carried out on untreated AP217 cells and on AP217 cells grown in the presence of PMA for 72 h (Figure 3, lanes 2 and 3 respectively) . After amplification and hybridization, a fl1 mRNA relative intensity of 69 was obtained for untreated cells and this value decreased to 20 for PMAtreated cells. The level of cell surface expression of /31 integrin protein on AP217 decreased from 81 % to 20 % within 48 h of PMA treatment and then remained stable (around 4 %) at 72 h and 120 h (Figure 2b) . Therefore the low level of expression of/il integrin subunit is probably due either to a decrease in transcription of /81 mRNA or to a higher turnover rate of that message.
DISCUSSION
Differentiation of haematopoietic cells in bone marrow or in lymphoid organs and their transport to the bloodstream depends on their adherence to extracellular matrix [33] . Erythroblastic cells (such as HEL and LAMA-84) treated with PMA become adherent and committed to the megakaryocytic lineage [12, 14] . Phorbol esters are thus convenient tools to promote in vitro commitment and were used in this work to study the relationship between adhesion receptors and megakaryocytopoiesis. We have established a novel erythromegakaryocytic cell line (AP217) which, when exposed to PMA, behaved mostly like the HEL cell line but did not become adherent. This has given us the opportunity to identify components that might be involved in PMA-induced adhesion. During normal megakaryocytic differentiation, several markers appear at the cell surface. The allb,/3 integrin is expressed in immature megakaryocytes, being one of the most specific, and the a6 integrin is a marker of mature megakaryocytes [34] . In the three cell lines studied (LAMA-84, HEL and AP217), phorbol esters induced cell surface expression of the platelet integrin allb,/3; however, the integrin subunit a6 was never detected at the cell surface. Conversely, the phosphotyrosine phosphatase receptor (CD45), which is expressed on early megakaryocytes and is absent on mature megakaryocytes and platelets [35] , was still present after PMA treatment. Therefore, PMA did induce differentiation of these leukaemia cell lines towards the megakaryocytic lineage but did not seem to promote maturation.
It has been suggested that the adherent phenotype of HEL which appears after PMA treatment is partly mediated by the activation of the aIlb,/3 integrin at the cell surface [17] . We used a monoclonal antibody (AC7) specific to the activated state of allb/33 [18] to test this hypothesis. We found that the integrin allb,/3 was not present on the surface of the cells in the highaffinity conformational state; nevertheless, we cannot exclude the possible existence of multiple functional forms of the integrin allb,83 that may not be recognized by AC7. However, when taken together with the observation that AP217 cells also expressed integrin allb,83 at high level and were non-adherent, it is likely that the integrin aIIb,83 is not playing a significant role in the PMA-induced adhesion of erythromegakaryocytic cell lines.
To determine which receptors might mediate the adherent phenotype of these cells, we quantified the cell surface expression of other integrin subunits. A comparison between cell surface receptors expressed in the two adherent cell lines (LAMA-84 and HEL) and in the non-adherent cell line (AP217) supported the involvement of /31 integrins in the adhesive phenotype. After PMA treatment, the /61 integrin subunit disappeared from the AP217 cell surface and its synthesis was dramatically decreased due either to an inhibition at the gene transcription level or to an increased RNA turnover. Conversely, in LAMA-84 and HEL cells, the /31 integrin subunit was still present regardless of PMA treatment. In these two cell lines, PMA treatment was followed by a down-regulation of ca4 and a.5 and an up-regulation of ax2 treatment express /31, a4 and ae5 and are non-adherent. Since we know that a4fll and ac5f1 might exist in multiple conformations [36, 37] In the three erythromegakaryocytic cell lines, PMA profoundly modified the expression of integrins at the cell surface, and both up-and down-regulation was observed. Interestingly, in other systems, enhancement of adherence by phorbol esters did not always involve up-regulation of receptor expression; in Tlymphocytes, adherence to c llagen and fibronectin was mediated by a2/31 and a5,81 and PMA increased only the functionality of these structures [40] . Danilo and Juliano [41] have also reported that the marked enhancem nt of Chinese hamster ovary cell adhesion to fibronectin, follc wing phorbol ester treatment, is not due to changes in the cell surface expression or in the affinity of the fibronectin receptor. so, phorbol esters stimulate RNA transcription of the fibronectin receptor in K 562 cells, but the newly synthesized integrin is poorly functional due to altered glycosylation [42] .
This work was performed in the absence of added matrix, since we know that the matrix itself can modify cell surface receptor expression and localization. We have not identified the ligands involved in the adhesion process, but we found that serum was essential. Cells probably do secrete matrix proteins, like fibronectin or collagen, that may play a role in the adhesion. Thrombospondin has been suspected of being a major extracellular matrix molecule involved in the adhesion of erythroleukaemia cell lines. However, we did not find any correlation between the expression of the thrombospondin receptor, CD36, at the cell surface and the adhesive phenotype since this expression remained high in the non-adherent AP217 cells.
If PMA treatment of HEL and LAMA-84 cells promoted an integrin shift at the cell surface from a4 and a5 to a2 and av, PMA was unable to transduce the same signal in AP217 cells. The failure may be due to the lack of some protein kinase C isoenzymes [13] , or to cell molecule regulators [43, 44] 
